Yaoyanshe, a Chinese clinical research organization (CRO) service provider, has raised RMB300 million (US$42.61 million) in a series C round of financing led by Chinese venture capital firm Eastern Bell Capital and Sequoia Capital China. Returning investors Matrix Partners China, Vision Plus Capital and Genesis Capital all poured money into the new round, said Huaxing […]

Sequoia, Eastern Bell Co-Lead $42M Series C Round In Chinese CRO Service Provider comes originally from China Money Network. All Rights Reserved.